- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
OS Therapies Appoints Moderna Co-Founder to Strategic Advisory Board
Dr. Robert Langer, a renowned biotech pioneer, will advise on the company's oncology pipeline and drug development.
Apr. 14, 2026 at 9:05am
Got story updates? Submit your updates here. ›
A symbolic representation of the innovative biotechnology research at OS Therapies, as the company bolsters its advisory board with the addition of renowned scientist Dr. Robert Langer.Cambridge TodayOS Therapies Inc. announced the appointment of Dr. Robert "Bob" S. Langer, co-founder of Moderna, to the company's strategic advisory board. Dr. Langer, a luminary in the field of biotechnology, will assist OS Therapies with prioritizing its listeria oncology pipeline, exploring combinations of listeria products with other oncology technologies, and selecting candidates for further development of its tunable Antibody Drug Conjugate (tADC) platform.
Why it matters
The addition of Dr. Langer, a highly respected and accomplished scientist, to OS Therapies' advisory board is a significant boost for the company's oncology research and development efforts. His expertise and guidance are expected to accelerate the company's progress in bringing innovative cancer treatments to market.
The details
Dr. Langer is one of the most influential figures in biotechnology, having developed core technologies used throughout the industry for drug discovery and development. His pioneering work includes isolating the first angiogenesis inhibitors, creating the first nanoparticles and microparticles for delivering large molecules, and helping establish the field of tissue engineering. Dr. Langer has authored over 1,600 papers, holds 44 honorary doctorates, and has co-founded more than 40 ventures, including Moderna.
- OS Therapies announced Dr. Langer's appointment on April 14, 2026.
The players
OS Therapies Inc.
A biotechnology company focused on developing innovative cancer treatments, including its listeria oncology pipeline and tunable Antibody Drug Conjugate (tADC) platform.
Dr. Robert "Bob" S. Langer
A renowned biotech pioneer, co-founder of Moderna, and one of the most cited engineers in history. He has developed core technologies used throughout the biotechnology industry and has been recognized with numerous prestigious awards, including the U.S. National Medal of Science and the National Medal of Technology and Innovation.
What they’re saying
“We are thrilled to welcome Dr. Langer to our strategic advisory board. His deep expertise and pioneering work in biotechnology will be invaluable as we continue to advance our oncology pipeline and explore new therapeutic approaches.”
— OS Therapies CEO
What’s next
OS Therapies plans to leverage Dr. Langer's guidance to prioritize its listeria oncology pipeline, explore combination therapies, and select tADC candidates for further development.
The takeaway
The appointment of Dr. Robert Langer, a renowned biotech innovator, to OS Therapies' strategic advisory board underscores the company's commitment to advancing its oncology research and development efforts. His expertise and insights are expected to play a crucial role in shaping the company's future product pipeline and strategic direction.
